STAT

NOVEMBER 9, 2023

A panel of government advisers finally has endorsed ideas for Congress to solve the particularly thorny problem of surprise ambulance bills , including a cap on how much patients would have to pay if they took an ambulance. Surprise bills have been eliminated for most health care services, but people who take out-of-network ground ambulances remain broadly unprotected — facing potentially thousands of dollars and the threat of collections for a ride that nobody really asks for.

Hospitals 320

Hospitals 320

PharmaVoice

NOVEMBER 9, 2023

A gene editing therapy developed by Vertex Pharmaceuticals and CRISPR Therapeutics can mute sickle cell disease’s most damaging symptoms. Yet treatment may not be as simple as its dramatic benefit makes it seem.

246

246

STAT

NOVEMBER 9, 2023

In my decade living in Silicon Valley as a digital health journalist and now an investor, I can’t tell you how many times I’ve heard people in the tech industry claim that doctors don’t have what it takes for a career in entrepreneurship. As the traditional thinking goes, because they’re so risk-averse and lack business training, physicians are not well suited to a high-growth, venture-backed startup environment.

318

318

PharmaVoice

NOVEMBER 9, 2023

The maze of ethical issues in biopharma can confound even the wiliest executive. How do some leaders get by?

147

147

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

NOVEMBER 9, 2023

NEW YORK — Surgeons have performed the world’s first transplant of an entire human eye, an extraordinary addition to a face transplant — although it’s far too soon to know if the man will ever see through his new left eye. An accident with high-voltage power lines had destroyed most of Aaron James’ face and one eye.

306

306

Pharma Times

NOVEMBER 9, 2023

The WID-qEC test successfully identified 91% of womb cancer cases - News - PharmaTimes

143

143

PharmaVoice

NOVEMBER 9, 2023

With its long-time CEO on the way out, the rare disease biotech has seen an activist investor grow its stake.

130

130

STAT

NOVEMBER 9, 2023

When Jason Farley was growing up in rural Alabama as a young gay man, he faced a lot of prejudice. “Everything I heard was like I was going to wake up one day and God was going to smite me with AIDS,” he said.

290

290

Pharma Times

NOVEMBER 9, 2023

The campaign was first launched to coincide with the 75th anniversary of the NHS - News - PharmaTimes

119

119

STAT

NOVEMBER 9, 2023

Apple has for years promised that its devices can help people live healthier, but it has so far produced little concrete evidence of this benefit. Many of the company’s health tools are consumer features without strong ties to the health care system, so there often isn’t a health care outcome to measure as proof. Nevertheless, Apple has embarked on several systematic studies exploring how its devices might be used to more directly improve health conditions, and after several years,

280

280

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

European Pharmaceutical Review

NOVEMBER 9, 2023

Following her presentation on age-related disease at BioFuture 2023, Executive Vice President of Drug Development for MyMD Pharmaceuticals ® , Jenna Brager, shares with EPR why the company’s next-generation tumour necrosis factor (TNF)-alpha inhibitor has potential in inflammatory and autoimmune disorders. In July 2023, MyMD Pharmaceuticals released results from its Phase II study in sarcopenia evaluating potential of MYMD-1 ® , its first-in-class oral TNF-α inhibitor.

Drug Development 115

Drug Development Immunity Immunization Pharmaceutical Companies 115

STAT

NOVEMBER 9, 2023

What’s a radiopharmaceutical? What does it mean to be Zepbound? And who’s to blame for a biotech blow-up? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. As so-called radiopharmaceuticals make headlines in oncology, we explore their fascinating scientific backstory and the biotech gold rush to make them.

210

210

Pharmaceutical Technology

NOVEMBER 9, 2023

GlobalData analyst Jemima Walker discusses key topics around cloud computing for the pharmaceutical industry.

114

114

STAT

NOVEMBER 9, 2023

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine. Sign up here to receive it in your inbox on Tuesdays and Thursdays. And then there were five (well, six) A pared-back field of five GOP presidential candidates sparred Wednesday night, touching on health issues ranging from hot-button election topics, to wonky budget math.

Diabetes 185

Diabetes Hospitals 185

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

BioPharma Dive

NOVEMBER 9, 2023

Shares in the biotech tumbled by 75% as results from a Phase 2 trial showed more improvement in participants given a placebo.

113

113

STAT

NOVEMBER 9, 2023

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with a counterintuitive idea in pharma, an ode to scientific matrimony, and the solution to a CAR-T mystery.

169

169

The Pharmacist

NOVEMBER 9, 2023

A fresh call has been made for a nationally commissioned non-referral smoking cessation service through community pharmacies, as the government announces major investment in local schemes. In the King’s Speech this week, it was revealed that the funding available to local smoking cessation services would ‘more than double’ by next April to £140m, while plans […] The post Renewed call for national non-referral smoking cessation service appeared first on The Pharmacist.

Community Pharmacies 111

Community Pharmacies 111

European Pharmaceutical Review

NOVEMBER 9, 2023

Sandoz and Teva have become the first organisations to qualify for the new global Minimized Risk of Antimicrobial Resistance (AMR) certification. This programme was developed by the British Standards Institute (BSI) to verify companies that are taking the necessary steps in ensuring responsible antibiotic manufacturing in the global supply chain, helping to lower the spread of AMR.

Pharmaceutical Manufacturing 111

Pharmaceutical Manufacturing 111

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

pharmaphorum

NOVEMBER 9, 2023

Takeda bags FDA okay for Fruzaqla in colorectal cancer Phil.

109

109

Express Pharma

NOVEMBER 9, 2023

USV and Biogenomics announced the launch of INSUQUICK, biosimilar Insulin Aspart. A company statement informed, “InsuQuick is a “Make in India” product, developed and manufactured using 100 per cent indigenous technology, and has undergone a robust clinical program to ensure global quality standards. It is available in all metros, and Tier I/II cities.

Biosimilars 105

Biosimilars Diabetes 105

pharmaphorum

NOVEMBER 9, 2023

Medicine, Media, Metamorphosis: How M3 is championing medical communications for modern healthcare Mike.

Communication 108

Communication 108

PharmExec

NOVEMBER 9, 2023

Solomon discusses new ways that researchers are fighting against bacterial resistance to medications.

105

105

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

World Pharma News

NOVEMBER 9, 2023

Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement therapy (ERT) in adult and pediatric patients with congenital thrombotic thrombocytopenic purpura (cTTP), a rare and life-threatening blood clotting disorder.

105

105

pharmaphorum

NOVEMBER 9, 2023

FH23: AI and humanity, a relationship for the future Mike.

105

105

The Pharmacist

NOVEMBER 9, 2023

The chief executive of NHS England (NHSE), Amanda Pritchard, will be called before the Health and Social Care Committee’s (HSCC) pharmacy inquiry, which is expected to begin later this month. The inquiry is set to look at the Additional Roles Reimbursement Scheme (ARRS), workforce issues, proposed legislative changes to pharmacy supervision and hub and spoke […] The post Pharmacy inquiry will question NHSE chief exec appeared first on The Pharmacist.

105

105

PharmExec

NOVEMBER 9, 2023

A look into the potential effect of psychedelic drugs on various illnesses, such as mental health conditions.

98

98

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Welltopia Pharmacy

NOVEMBER 9, 2023

Vitamins for Healthy Teeth and Bones: Importance of dental and skeletal health, Oral hygiene: Good dental health prevents tooth decay.

98

98

European Pharmaceutical Review

NOVEMBER 9, 2023

Daiichi Sankyo’s VANFLYTA ® (quizartinib) is the first FLT3 inhibitor to be approved in the EU for newly diagnosed FLT3 -ITD positive acute myeloid leukaemia (AML). The European Commission (EC) has authorised the anti-cancer treatment in combination with standard cytarabine and anthracycline induction and standard cytarabine consolidation chemotherapy, followed by VANFLYTA single-agent maintenance therapy for adult patients with newly diagnosed acute myeloid leukaemia that is FLT3 -ITD positiv

Chemotherapy 98

Chemotherapy Hospitals 98

PharmExec

NOVEMBER 9, 2023

Healthy Food Rx provides home-delivered medical prescriptions of healthy food to help address diabetes.

Diabetes 97

Diabetes 97

European Pharmaceutical Review

NOVEMBER 9, 2023

Issue 5 of European Pharmaceutical Review features articles on manufacturing, development and quality control of biopharmaceuticals from antibodies to mRNA and cell and gene therapies. In this issue, Peter Stenico, Biosimilar Global Platform Head at Sandoz, highlights how emerging technology platforms such as nanobodies, ADCs and cell and gene therapies are “on course to revolutionise medicine,” with significant growth anticipated over the next decade.

Biosimilars 98

Biosimilars Drug Development 98

pharmaphorum

NOVEMBER 9, 2023

AstraZeneca builds in obesity with $2bn+ Eccogene deal Phil.

94

94